title: TGIF Mutations in Human Holoprosencephaly: Correlation between Genotype and Phenotype.
abstract: Holoprosencephaly (HPE), which results from failed or incomplete midline forebrain division early in gestation, is the most common forebrain malformation. The etiology of HPE is complex and multifactorial. To date, at least 12 HPE-associated genes have been identified, including TGIF (transforming growth factor beta-induced factor), located on chromosome 18p11.3. TGIF encodes a transcriptional repressor of retinoid responses involved in TGF-β signaling regulation, including Nodal signaling. TGIF mutations are reported in approximately 1-2% of patients with non-syndromic, non-chromosomal HPE. We combined data from our comprehensive studies of HPE with a literature search for all individuals with HPE and evidence of mutations affecting TGIF in order to establish the genotypic and phenotypic range. We describe 2 groups of patients: 34 with intragenic mutations and 21 with deletions of TGIF. These individuals, which were ascertained from our research group, in collaboration with other centers, and through a literature search, include 38 probands and 17 mutation-positive relatives. The majority of intragenic mutations occur in the TGIF homeodomain. Patients with mutations affecting TGIFrecapitulate the entire phenotypic spectrum observed in non-chromosomal, non-syndromic HPE. We identified a statistically significant difference between the 2 groups with respect to inheritance, as TGIF deletions were more likely to be de novo in comparison to TGIF mutations (χ(2) ((2)) = 6.97, p(permutated) = 0.0356). In addition, patients with TGIF deletions were also found to more commonly present with manifestations beyond the craniofacial and neuroanatomical features associated with HPE (p = 0.0030). These findings highlight differences in patients with intragenic mutations versus deletions affecting TGIF, and draw attention to the homeodomain region, which appears to be particularly relevant to HPE. These results may be useful for genetic counseling of affected patients.
authors: Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Md.
authors: A A
authors: AA
authors: Keaton
authors: B D
authors: BD
authors: Solomon
authors: E F
authors: EF
authors: Kauvar
authors: K B
authors: KB
authors: El-Jaick
authors: A L
authors: AL
authors: Gropman
authors: Y
authors: Y
authors: Zafer
authors: J M
authors: JM
authors: Meck
authors: S J
authors: SJ
authors: Bale
authors: D K
authors: DK
authors: Grange
authors: B R
authors: BR
authors: Haddad
authors: G C
authors: GC
authors: Gowans
authors: N J
authors: NJ
authors: Clegg
authors: M R
authors: MR
authors: Delgado
authors: J S
authors: JS
authors: Hahn
authors: D E
authors: DE
authors: Pineda-Alvarez
authors: F
authors: F
authors: Lacbawan
authors: J I
authors: JI
authors: Vélez
authors: E
authors: E
authors: Roessler
authors: M
authors: M
authors: Muenke